Ibrance® (palbociclib), Kisqali® (ribociclib), and Verzenio® (abemaciclib) – New Warning
September 13, 2019 - The FDA announced that the Warnings and Precautions sections of the Ibrance (palbociclib), Kisqali (ribociclib), and Verzenio (abemaciclib) drug labels were updated with information regarding interstitial lung disease (ILD) and pneumonitis.
Top